Today, roughly 3.5 million people in the US use cannabis for effective relief of various symptoms related to epilepsy, multiple sclerosis, Crohn’s disease, cancer treatment, Parkinson’s, and Alzheimer’s.
Experts believe these numbers will grow exponentially in the coming years – and the Hebrew University of Jerusalem (HU) is perfectly positioned to research and develop many of the medical use cases of cannabis.
Professor Raphael Mechoulam began studying cannabinoids at HU in 1964. Today he is widely recognized as the “godfather” of cannabis. He was curious how researchers had isolated morphine from opium over 150 years ago and cocaine from coca leaves a century prior, yet no one had tried to understand cannabis and its psychoactive and non-psychoactive ingredients. To develop medical marijuana, Mechoulam and his colleagues became their own test subjects and after a few months not only understood the plant’s chemical make-up, but found a way to test its medicinal properties.
Today, thanks to Professor Mechoulam’s research over the past half century, doctors around the world prescribe cannabinoids for a variety of disorders. Mechoulam’s work catapulted Israel to the top of the field of cannabinoid research.
This is just one example of the work you fund when you give to American Friends of the Hebrew University.
Learn more about Hebrew University’s groundbreaking work in cannabis research, agriculture, technology, medicine, internet security, and more today.